Article
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
27 Oct 2023
Abstract excerpt
Abstract Rift Valley fever virus (RVFV) is listed as a priority pathogen by the World Health Organization (WHO) because it causes serious and fatal disease in humans, and there are currently no effective countermeasures. Therefore, it is urgent to develop a safe and efficacious vaccine. Here, we developed six nucleotide-modified mRNA vaccines encoding different regions of the Gn and Gc proteins of RVFV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
